Creo Medical Group PLC (CREO)

London
19.59
-0.16(-0.81%)
  • Volume:
    103,568
  • Bid/Ask:
    19.50/20.00
  • Day's Range:
    19.55 - 20.00

CREO Overview

Prev. Close
19.75
Day's Range
19.55-20
Revenue
25.9M
Open
20
52 wk Range
19.5-178.86
EPS
-0.16
Volume
103,568
Market Cap
35.6M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
145,976
P/E Ratio
-1.25
Beta
1.18
1-Year Change
-83.26%
Shares Outstanding
178,545,885
Next Earnings Date
21 May 2023
What is your sentiment on Creo Medical?
or
Vote to see community's results!

Creo Medical Group PLC News

Creo Medical Group PLC Analysis

  • Creo Medical: Initiation Of Coverage
    • ByEdison Group-

    We are initiating coverage of Creo Medical (LON:CREO), which is developing and commercialising minimally invasive electrosurgical devices. Its CROMA platform delivers a combination...

Creo Medical Group PLC Company Profile

Creo Medical Group PLC Company Profile

Creo Medical Group plc is engaged in the research and development and the manufacture and sale of medical devices and instruments. The Company is focused on the research, development, and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. It has four technology families, which include Speedboat, SpydrBlade, MicroBlate, and SlypSeal. Speedboat is its flagship advanced energy device product with over 1,000 procedures performed using the device. Speedboat device technology is a device technology with bipolar surgical dissection blade in any form of surgery. Additionally, Speedboat integrates microwave technology allowing for precise control of bleeding during surgery. The Company's SpydrBlade device technology optimizes the power of its CROMA Platform, where advanced bipolar radiofrequency (RF) energy is used to cut tissue and precisely controlled microwave energy is used for the coagulation and sealing of tissue during surgery.

Read More

Analyst Price Target

Average205.00 (+946.45% Upside)
High205.00
Low205.00
Price19.59
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsBuyStrong BuyStrong BuyStrong SellSell
SummaryStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
  • creo has developed and patented an incredible low-impact surgical system that can operate on the most delicate bodily organs with robotic assistance, cauterising as it goes. It is fully operational and being bought by hospitals and other medical facilities worldwide. The word is out among surgeons and the company os going to burgeon very soon. Don't wait.
    0